正对的IMiD-Degron对诱导细胞中的选择性蛋白质降解
Patrick J Brennan1,2, Rebecca E Saunders3, Mary Spanou4
1Department of Chemistry, Chemistry Research Laboratory, University of Oxford, OX1 3TA Oxford, U.K.
ACS chemical biology
|November 2, 2025
概括
研究人员开发了一种使用改性免疫调节性胺基药物 (IMiDs) 选择性降解标蛋白的新方法. 这种方法通过向突变的指 (ZF) 降解子来提高特异性,避免基本细胞蛋白质的降解.
科学领域:
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
- 蛋白质组学是指蛋白质组学.
背景情况:
- 免疫调节性伊米德药物 (IMiDs),如莱纳利多米德,通过指 (ZF) 图案诱导蛋白质降解.
- 目前的IMID缺乏选择性,降解了无意中含有ZF的蛋白质 (例如IKZF1,IKZF3,SALL4).
研究的目的:
- 设计一种选择性蛋白质降解系统,使用修改后的IMiDs.
- 为了克服现有的基于ZF的降解系统缺乏特异性.
主要方法:
- 使用"撞孔"策略创建突变的ZF蛋白质和新的IMiD类似物.
- 选了8380个ZF突变体与撞击IMiD类似物进行选择性结合和降解.
- 通过诱导与工程降解合的目标蛋白质的降解来验证系统.
主要成果:
- 开发了一种撞击型IMiD模拟物,可以选择性地降解突变ZF降解物.
- 证明了新的IMiD类似物不会降解内源ZF蛋白 (IKZF1,IKZF3,SALL4).
- 成功地将该系统应用于降解CDK9,HPRT1,NanoLuc和TRIM28.28等蛋白质.
结论:
- 开发的系统为目标蛋白质降解提供了增强的选择性.
- 这种新的方法扩大了生物研究和药物发现中可诱导蛋白质降解的工具包.
- 该系统有可能用于目标验证和治疗策略中的应用.
更多相关视频
05:33High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
10.9K
07:08Optimization of Synthetic Proteins: Identification of Interpositional Dependencies Indicating Structurally and/or Functionally Linked Residues
Published on: July 14, 2015
7.6K
相关概念视频
Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K
Regulated Protein Degradation
3.0K
3.0K
The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Unfolded Protein Response
6.2K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.2K
Export of Misfolded Proteins out of the ER
4.9K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.9K
